CDG Invest Growth exits Techniques Science-Santé (T2S)

14 décembre 2021

CDG Invest Growth announces the completion of its exit from Techniques Science-Santé (T2S) through a sale to a holding company owned by Helios investment fund.

CDG Invest Growth acquired a significant minority stake in T2S in June 2016 through the Capmezzanine II fund.

Founded in 1992 by Mr. Abderraouf Sordo and his four partners, T2S has become, in less than three decades, the undisputed leader in the distribution and maintenance of medical equipment in Morocco and then in French-speaking Africa, with revenues of around 700 Mdhs in 2020. T2S’s success is the result of long-standing relationships with leading medical device manufacturers, as well as the trust and legitimacy it enjoys with its customers.

Click here for more information about T2S

August 1, 2023

CDG Invest Growth acquires a stake in Agri Trade Maroc

CDG Invest Growth acquires a significant minority stake in Agri Trade Maroc, a leading player in fertilizers’ distribution in Morocco and a subsidiary of SCE Group. This operation aims to support ATM’s growth on the conventional fertilizers segment and strengthen its presence on the speciality fertilizers market in Morocco and the African continent. Nadia Tarari, […]

April 1, 2019

CDG Invest Growth invests in Oncorad, a leading operator in oncology in Morocco

CDG Invest Growth, the leading growth equity investor in Morocco invested in Group Oncorad, a private healthcare provider focused on oncology and radiology. Oncorad was founded in 1999 by Pr. Redouane Samlali and Dr. Omar Hajji. Their first center was Clinique le Littoral which opened in 2000 in Casablanca. Through the years, Clinique le Littoral […]

December 1, 2021